EPO in treatment of autoimmune hemolytic anemia

BestPractice | Jun 2019 | |

In this MEDtalk Sigbjørn Berentsen present data that advise EPO use to stimulate bone marrow compensatory response. The results from this international studyshows, that EPO is effective in about 70% of AIHA patients unresponsive to ongoing/previous treatments.